Does LORAZEPAM Cause Hyperammonaemic encephalopathy? 37 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 37 reports of Hyperammonaemic encephalopathy have been filed in association with LORAZEPAM (Lorazepam). This represents 0.1% of all adverse event reports for LORAZEPAM.
37
Reports of Hyperammonaemic encephalopathy with LORAZEPAM
0.1%
of all LORAZEPAM reports
0
Deaths
21
Hospitalizations
How Dangerous Is Hyperammonaemic encephalopathy From LORAZEPAM?
Of the 37 reports, 21 (56.8%) required hospitalization, and 7 (18.9%) were considered life-threatening.
Is Hyperammonaemic encephalopathy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LORAZEPAM. However, 37 reports have been filed with the FAERS database.
What Other Side Effects Does LORAZEPAM Cause?
Drug ineffective (3,775)
Drug abuse (3,741)
Toxicity to various agents (2,836)
Completed suicide (2,340)
Off label use (2,178)
Somnolence (2,114)
Sopor (2,042)
Anxiety (1,573)
Fall (1,524)
Overdose (1,516)
What Other Drugs Cause Hyperammonaemic encephalopathy?
VALPROIC ACID (455)
FLUOROURACIL (156)
VALPROATE (120)
DIVALPROEX (119)
OXALIPLATIN (107)
TOPIRAMATE (101)
RISPERIDONE (96)
QUETIAPINE (91)
LEVETIRACETAM (71)
LEUCOVORIN (62)
Which LORAZEPAM Alternatives Have Lower Hyperammonaemic encephalopathy Risk?
LORAZEPAM vs LORCASERIN
LORAZEPAM vs LORLATINIB
LORAZEPAM vs LORMETAZEPAM
LORAZEPAM vs LORNOXICAM
LORAZEPAM vs LOSARTAN